Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,230
Closed -$203K 97
2025
Q1
$203K Hold
1,230
0.1% 85
2024
Q4
$200K Hold
1,230
0.09% 83
2024
Q3
$240K Sell
1,230
-100
-8% -$18.4K 0.11% 79
2024
Q2
$231K Hold
1,330
0.12% 81
2024
Q1
$225K Hold
1,330
0.14% 87
2023
Q4
$263K Buy
1,330
+100
+8% +$17.7K 0.19% 72
2023
Q3
$214K Hold
1,230
0.17% 76
2023
Q2
$212K Hold
1,230
0.16% 81
2023
Q1
$205K Buy
+1,230
New +$202K 0.17% 82

Other funds holding ZTS

Ted Buchan & Co's ZTS Position: Q2 2025 in Review

Ted Buchan & Co sold out of Zoetis (ZTS) in Q2 2025, closing a stake of 1,230 shares — an estimated $203K sold.

Ted Buchan & Co first reported a position in ZTS in Q1 2023 and held it in 9 quarters. The position peaked at $263K in Q4 2023. 1,870 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • Ted Buchan & Co reported no remaining Zoetis position as of Q2 2025 after selling out during the quarter.
  • Ted Buchan & Co sold 1,230 Zoetis shares in Q2 2025, an estimated $203K.
  • Ted Buchan & Co first reported a position in Zoetis in Q1 2023 and held it in 9 quarters.
  • Ted Buchan & Co's Zoetis position peaked at $263K in Q4 2023.
  • 1,870 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on Ted Buchan & Co's 13F filing for Q2 2025, filed 13 Aug 2025.